人血清中A、C、Y、W135群脑膜炎球菌荚膜多糖IgG抗体含量ELISA检测方法的建立
[Abstract]:Aim to establish a ELISA method for quantitative determination of anti A, C, Y, W135 meningococcal capsule polysaccharide Ig G antibody in human serum and verify it. Methods the suitable enzyme plate was screened, the concentration of antigen coated was optimized, the key conditions of ELISA detection process were determined, and the specificity, linearity, accuracy, precision, minimum detection value and stability of the established ELISA method were verified. And establish the laboratory quality control serum quality control detection range. Results the intraplate CV and inter-plate CV were 9.8% and 16.4% respectively. There was a significant dose-dependent relationship between the group-specific antibody content and the absorbed dose of the same-group polysaccharide. There was a negative correlation between the content of each group of Ig-G antibody and the dilution of the serum in the 12 CDC quality-controlled sera of the United States. The correlation coefficient (r) and slope (slope) are both close to-1, and the linear relationship is good. The correlation coefficients A, C, W135 and Y were 0.912, 0.939 6, 0.963 7 and 0.920 6, respectively. The results were in good agreement with CDC published data. The intra-and inter-test precision of each group of Ig-G antibody in the internal quality control serum Men20 was less than 10% and 20%, respectively, and the precision was better, the CV value of each serum group was 30%, and the stability was good. The lowest detection values of Ig G antibody in A, C, Y, W135 polysaccharide groups were 0.092, 0.118, 0.067 and 0.035 渭 g / ml, respectively, the detection ranges were 92.49 渭 g / ml, 37.29 渭 g / ml., 66.18 渭 g / ml. and 50.15 ~ 23.31 渭 g / ml., respectively. Conclusion A standardized ELISA method was established for the determination of anti-A, C, Y, W135 group meningococcal polysaccharide Ig G antibody in human serum, and the range of quality control detection value of Men20 in laboratory routine quality control serum was determined. [WT5 "HZ] conclusion\ [WT5" BZ]
【作者单位】: 兰州生物制品研究所有限责任公司甘肃省疫苗工程技术研究中心;中国食品药品检定研究院;美国阿拉巴马大学伯明翰分校病理学系呼吸道病原参考实验室;中国生物技术股份有限公司;
【基金】:国家科技支撑计划课题(2008BAI66B01) 国家“重大新药创制”专项(2013ZX09402-302-215) 甘肃省科技重大专项(0801NKDA003) 甘肃省“十二五陇药产业发展”专项
【分类号】:R378.15;R392-33
【相似文献】
相关期刊论文 前10条
1 鲍莉;;各种静脉注射用免疫球蛋白制品的特征:Ⅰ.蛋白成份和抗体含量[J];国外医学.生物制品分册;1983年02期
2 周学良;;人初乳中抗霍乱抗体的保护力[J];国外医学.生物制品分册;1983年03期
3 高建炜;曹守勤;郝琼;闫立群;;2006年宁夏三市健康人群血清流脑抗体含量分析[J];宁夏医学杂志;2008年07期
4 王晓明,郑霞清,龙存国,张国元,李秋茹;急性闭合性颅脑损伤患者血清髓鞘碱性蛋白及其抗体含量的研究[J];临床神经病学杂志;1997年04期
5 李红;唐静;李茂光;李亚南;何莉;叶强;;ELISA方法测定血清中Hib多糖抗体含量的条件比较研究[J];微生物学免疫学进展;2009年01期
6 许秀芳;Rieben R;;体外循环保存离体猪肢体实验中IgG和IgM抗体含量变化的研究[J];心肺血管病杂志;2008年04期
7 程金华;;应用ELISA方法检测老年动脉粥样硬化患者血清抗负电性低密度脂蛋白自身抗体含量[J];中国老年学杂志;2012年16期
8 韩晓芳,宋壮志,李慧君,王文灏,吴翠平,杜英,梁建林;SARS患者特异性抗体水平的动态监测[J];中华医院感染学杂志;2004年11期
9 ;[J];;年期
10 ;[J];;年期
相关会议论文 前1条
1 张晟;罗弟祥;刘怡;何刚;李剑红;高小平;;抗体含量检测的生物膜干涉技术、HPLC及ELISA的比较[A];2012年中国药学大会暨第十二届中国药师周论文集[C];2012年
,本文编号:2442796
本文链接:https://www.wllwen.com/yixuelunwen/binglixuelunwen/2442796.html